2m 2m 2m 2m 2m 2m 2m
ERASCA (ERAS)
NASDAQ
$17.28+$1.80 (+11.63%)
Price as of Nov 11, 2026 7:35 PM EST- $5.4BMarket Cap
- 555.93%1-Year Change
- BiotechnologyIndustry
ERASCA (ERAS)
$17.28+$1.80 (+11.63%)
ERAS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $15.48 | ||
Change | -$0.13 (-0.83%) | ||
Open | $15.43 | ||
High | $15.66 | ||
Low | $15.00 | ||
Previous Close | $15.61 | ||
Volume | 5,984,545 | ||
30-Day Average Volume | 4,679,532 | ||
1-Week Change | 5.74% | ||
1-Month Change | -3.43% | ||
1-Year Change | 555.93% | ||
3-Year Change | 670.15% | ||
5-Year Change | -17.97% | ||
Fundamentals | |||
Shares Outstanding | 349.8M | ||
Total Assets | $435.1M | ||
Market Cap | $5.4B | ||
Enterprise Value | $5.4B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$44.1M | ||
Free Cash Flow | -$27.3M | ||
EBIT | -$44.1M | ||
EBITDA | -$43.4M | ||
Net Working Capital | $244.9M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -124 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 15 | ||
P/E | -111 | ||
PEG | -1 | ||
Price/Free Cash Flow | -198 | ||
Price/Operating Cash Flow | -199 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue